These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33087058)

  • 1. Assaying the effect of yeasts on growth of fungi associated with disease.
    Horváth E; Sipiczki M; Csoma H; Miklós I
    BMC Microbiol; 2020 Oct; 20(1):320. PubMed ID: 33087058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
    Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
    BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
    Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
    Carrillo-Muñoz AJ; Tur-Tur C; Hernández-Molina JM; Quindós G; Marcos-Arias C; Eraso E; Cárdenes D; Ortiz-Maestro O; Santos P; Estivill D; Guardia C; Giusiano G
    Rev Esp Quimioter; 2010 Sep; 23(3):122-5. PubMed ID: 20844842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening the antifungal activities of monoterpenes and their isomers against Candida species.
    Iraji A; Yazdanpanah S; Alizadeh F; Mirzamohammadi S; Ghasemi Y; Pakshir K; Yang Y; Zomorodian K
    J Appl Microbiol; 2020 Dec; 129(6):1541-1551. PubMed ID: 32506599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species.
    De Toledo LG; Ramos MA; Spósito L; Castilho EM; Pavan FR; Lopes Éde O; Zocolo GJ; Silva FA; Soares TH; Dos Santos AG; Bauab TM; De Almeida MT
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia.
    Seyoum E; Bitew A; Mihret A
    BMC Infect Dis; 2020 Mar; 20(1):231. PubMed ID: 32188422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dear medical mycologists, it is time to look outside the box.
    Morio F
    FEMS Yeast Res; 2020 Feb; 20(1):. PubMed ID: 31738413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The yeast, the antifungal, and the wardrobe: a journey into antifungal resistance mechanisms of
    Oliveira JS; Pereira VS; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Brilhante RSN; Rocha MFG
    Can J Microbiol; 2020 Jun; 66(6):377-388. PubMed ID: 32319304
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanoemulsion as an Effective Treatment against Human-Pathogenic Fungi.
    Garcia A; Fan YY; Vellanki S; Huh EY; Vanegas D; Wang SH; Lee SC
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31852807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fruits as the vehicle of drug resistant pathogenic yeasts.
    Lo HJ; Tsai SH; Chu WL; Chen YZ; Zhou ZL; Chen HF; Lee CF; Yang YL
    J Infect; 2017 Sep; 75(3):254-262. PubMed ID: 28648496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.